ROIV

#569
Roivant Sciences Ltd. - Common Shares
30.2 7 USD
+1.31%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
30.13
30.28
Faixa anual
0.29
32.79
Mudança diária
+1.31%
Mudança mensal
+8.53%
Mudança em 6 meses
+47.80%
Mudança anual
+65.32%
Fechamento anterior
29.8 8
Open
30.1 7
Mínimo
30.1 3
High
30.2 8
Volume
1 090
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 21.77 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-51.3
Índice preço/fluxo de caixa
2 326.88

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Notícias